Back to results
US 2021/0330638 A1Published application
Nano-penetrative cannabinoid oil blends and compositions and methods of formulation thereof
OwnerTimothy Drennaninventor
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of formulating therapeutic oil blends comprising one or more terpenes, wherein the methods may result in blends exhibiting increased stability and bioavailability. The methods may be used to produce compositions for dermal or transdermal application useful in the treatment of, e.g., pain. Disclosed methods may also result in improved homogeneity and non-crystallization of the formulated products.
Claims26
1-68. (canceled)
A cavitated therapeutic oil blend comprising:
- a) 25-75% w/w cannabinoid content;
- and
- b) 25-75% w/w terpene content,
- wherein the cavitated therapeutic oil blend has an average cannabinoid crystal size of less than 300 nm at room temperature, wherein the cavitated therapeutic oil blend comprises cavitation bubbles, and wherein weight contents are calculated based on the weight of the cavitated therapeutic oil blend.
1 more element
A cavitated therapeutic oil blend that comprises:
- a) 25-90% w/w cannabidiol content;
- b) 25%-75% w/w terpene content, wherein the terpene content comprises:
- i) clove bud oil;
- ii) peppermint oil;
- or
- iii) both i) and ii),
- wherein the cavitated therapeutic oil blend has an average cannabinoid crystal size of less than 300 nm at room temperature, wherein the cavitated therapeutic oil blend comprises cavitation bubbles, and wherein weight contents are calculated based on the weight of the cavitated therapeutic oil blend.
4 more elements
A method of preparing a cavitated therapeutic oil blend, the method comprising:
- a) heating a cannabinoid under conditions sufficient to melt or dissolve the cannabinoid, thereby producing a liquid cannabinoid;
- b) admixing:
- i) 25-75% w/w liquid cannabinoid;
- and
- ii) 25-75% w/w terpene, thereby producing a mixture;
- and
- c) cavitating the mixture of step (b) under conditions sufficient to generate cavitation bubbles, thereby generating the cavitated therapeutic oil blend, wherein the cavitated therapeutic oil blend has an average cannabinoid crystal size of less than 300 nm at room temperature, and wherein weight contents are calculated based on the weight of the cavitated therapeutic oil blend.
4 more elements
Dependencies are inferred from the claim text.